SK
Singroha Kanika
About Singroha Kanika
Data last updated:
Singroha Kanika is a Director at Cellverse Private Limited (since 2022). The companies operate in Non-Profit Organizations. Cellverse Private Limited reported revenue of ₹2.1 Lakh (FY 2025). Earlier, Singroha Kanika was a Designated Partner at Nextgen Bio Meds Development And Gmp Consulting Llp (from 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cellverse Private Limited U85300RJ2022PTC084041 | Director | 30 Sep 2022 | 2022 | ₹2.1 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 19 Oct 2022 | 2022 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Singroha Kanika
| Name | DIN | Company | Designation |
|---|---|---|---|
| Devesh Rakhecha | 08407583 | Cellverse Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Singroha Kanika
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Singroha Kanika
Singroha Kanika currently holds 1 directorship: Cellverse Private Limited (Director, since 30 Sep 2022, revenue ₹2.1 Lakh (FY 2025)).
Singroha Kanika was first appointed on 30 Sep 2022 as Director at Cellverse Private Limited.
Singroha Kanika held 1 earlier board appointment: Nextgen Bio Meds Development And Gmp Consulting Llp (Designated Partner, from 19 Oct 2022).
The current boards of Singroha Kanika's companies include Devesh Rakhecha (Cellverse Private Limited).